Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
US7855205B2 · kind B2 · utility
7Cited by
0References
88Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2005 |
| Grant date | Dec 21, 2010 |
| Priority date | — |
| Expiry date | Jan 1, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides pyrimidinyl substituted fused-pyrrolyl compounds of Formula (I)and pharmaceutical compositions comprising the compounds and methods of synthesis and use thereof. The compounds are kinase inhibitors useful in treating or ameliorating a kinase mediated, angiogenesis-mediated or hyperproliferative disorder. The invention thus also provides a therapeutic or prophylactic method of use for the compounds and/or pharmaceutical compositions to treat such disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.